Biodesix Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biodesix Inc (BDSX)
Biodesix Inc stock price live, this page displays NASDAQ BDSX stock exchange data. View the BDSX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biodesix Inc real time stock price chart below.
What Is the Biodesix Inc Stock Price Today?
The Biodesix Inc stock price today is 22.550.
What Is the Stock Symbol for Biodesix Inc?
The stock symbol for Biodesix Inc is "BDSX."
What Stock Exchange Does Biodesix Inc Trade On?
Biodesix Inc is listed and trades on the NASDAQ stock exchange.
Is Biodesix Inc a Good Stock to Buy?
Determining whether Biodesix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BDSX quote. (ISIN: US09075X2071)
What Is the Biodesix Inc Stock Price Today?
The Biodesix Inc stock price today is 22.550.
What Is the Stock Symbol for Biodesix Inc?
The stock symbol for Biodesix Inc is "BDSX."
What Stock Exchange Does Biodesix Inc Trade On?
Biodesix Inc is listed and trades on the NASDAQ stock exchange.
Is Biodesix Inc a Good Stock to Buy?
Determining whether Biodesix Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BDSX quote. (ISIN: US09075X2071)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.580
24.220
52 wk Range
5.260
24.340
BDSX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.58024.220
52 wk Range
5.26024.340
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BDSX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
30.833
Upside
+36.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Form S-3 Biodesix Inc For: 21 May
- Investing.com
- Form 13G BIODESIX INC For: 18 June
- Investing.com
- Biodesix Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 13G BIODESIX INC For: 18 June
- Investing.com
- Biodesix Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 30.833
(+36.73% Upside)
Biodesix Inc Earnings Call Summary for Q1/2026
- Biodesix reported Q1 2026 revenue of $25.6M, up 42% YoY; raised full-year guidance to $108M-$114M from previous estimates.
- Diagnostic testing revenue grew 37% to $22.3M while development services nearly doubled to $3.3M; gross margins improved to 84%.
- Net loss narrowed 30% to $7.8M despite 18% increase in operating expenses; company continues progress toward profitability.
- CEO Scott Hutton emphasized expansion of primary care channel and pulmonologist relationships as key growth drivers for 2026.
- Stock rose 0.27% to $11.11 in after-hours trading; analysts set price targets between $20-$40, suggesting significant upside potential.
Last Updated: 2026-05-04, 05:12 p/m
Read Full TranscriptEarnings
Latest Release
May 04, 2026
EPS / Forecast
-0.81 / -0.05
Revenue / Forecast
25.56M / 23.1M
Compare BDSX to Peers and Sector
Metrics to compare | BDSX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBDSXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.1x | −14.7x | −0.4x | |
PEG Ratio | −0.24 | −0.47 | 0.00 | |
Price/Book | 25.0x | 5.5x | 2.6x | |
Price / LTM Sales | 2.4x | 11.5x | 3.0x | |
Upside (Analyst Target) | 26.0% | −19.0% | 51.8% | |
Fair Value Upside | Unlock | 5.4% | 7.2% | Unlock |
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient’s immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Biodesix (BDSX) Stock Price Today?
The Biodesix stock price today is 22.550 USD.
What Stock Exchange Does Biodesix Trade On?
Biodesix is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Biodesix?
The stock symbol for Biodesix is "BDSX."
What Is the Biodesix Market Cap?
As of today, Biodesix market cap is 240.690M USD.
What Is Biodesix's Earnings Per Share (TTM)?
The Biodesix EPS (TTM) is -3.926.
When Is the Next Biodesix Earnings Date?
Biodesix will release its next earnings report on Aug 12, 2026.
From a Technical Analysis Perspective, Is BDSX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Biodesix Stock Split?
Biodesix has split 1 times.
How Many Employees Does Biodesix Have?
Biodesix has 334 employees.
What is the current trading status of Biodesix (BDSX)?
As of Jun 30, 2026, Biodesix (BDSX) is trading at a price of 22.550 USD, with a previous close of 23.810 USD. The stock has fluctuated within a day range of 21.580 USD to 24.220 USD, while its 52-week range spans from 5.260 USD to 24.340 USD.
What Is Biodesix (BDSX) Price Target According to Analysts?
The average 12-month price target for Biodesix is 30.833 USD, with a high estimate of 40 USD and a low estimate of 26 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +36.73% Upside potential.
What Is the BDSX Premarket Price?
BDSX's last pre-market stock price is 24.330 USD. The pre-market share volume is 60.000, and the stock has decreased by 0.520, or 2.180%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.